Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02028000 · ClinicalTrials.gov registry record · NA
Postoperative Pain and Skin Closure Methods After Cesarean Section
A NA study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02028000 is a NA study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 10 participants.
The verdict
NCT02028000, a NA study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The study is looking at women undergoing cesarean section delivery of their baby. The purpose of this research study is to determine what type of skin closure after cesarean section helps decrease pain level the most and improves the appearance of the incision site. The study hypothesis is to determine if skin closure with absorbable subcuticular staples leads to improved cosmesis and/or decreased post-operative pain. Participants in the study will already be scheduled for a cesarean section for delivery of their baby. They will be randomized into one of three groups, 1) Insorb (absorbable subcuticular stapes), 2) Vicryl suture or 3) Monocryl suture for the skin closure of their cesarean section. Information that will be recorded includes amount of pain medication usage while in the hospital after cesarean section, daily patient rated pain score until discharge from hospital, pain score 6 weeks after surgery and cesarean section cosmetic scar 6 weeks after surgery.
Interventions
- PROCEDURE Insorb staples skin closure
- PROCEDURE Monocryl skin closure
- PROCEDURE Vicryl skin closure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-01 |
| Est. Completion | 2016-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02028000
The ClinicalTrials.gov registry entry for NCT02028000 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Insorb staples skin closure is the first listed.
NCT02028000 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02028000 about?
NCT02028000 is a clinical study titled "Postoperative Pain and Skin Closure Methods After Cesarean Section". The study is looking at women undergoing cesarean section delivery of their baby. The purpose of this research study is to determine what type of skin closure after cesarean section helps decrease pain level the most and improves the appearance of the incision site. The study hypothesis is to deter...
What is the current status of trial NCT02028000?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2012-01. Estimated completion is 2016-01-01.
What interventions are being tested in trial NCT02028000?
The interventions under investigation include: Insorb staples skin closure (PROCEDURE), Monocryl skin closure (PROCEDURE), Vicryl skin closure (PROCEDURE).
Who is sponsoring clinical trial NCT02028000?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.